The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 26, 2025

Filed:

Jul. 15, 2020
Applicants:

Sanofi Biotechnology, Paris, FR;

Regeneron Pharmaceuticals, Inc., Tarrytown, NY (US);

Inventors:

Heribert Staudinger, Bridgewater, NJ (US);

Ariel Teper, Bridgewater, NJ (US);

Nikhil Amin, Chappaqua, NY (US);

Sivan Harel, New York, NY (US);

Neil Graham, Croton-on-Hudson, NY (US);

Assignees:

SANOFI BIOTECHNOLOGY, Gentilly, FR;

REGENERON PHARMACEUTICALS, INC., Tarrytown, NY (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/12 (2006.01); A61K 39/00 (2006.01); A61P 11/06 (2006.01); C07K 16/28 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2866 (2013.01); A61K 39/12 (2013.01); A61P 11/06 (2018.01); A61K 2039/525 (2013.01); A61K 2039/545 (2013.01);
Abstract

Methods for treating or preventing asthma (e.g., allergic asthma, asthma associated with allergic bronchopulmonary aspergillosis (ABPA), moderate-to-severe asthma, persistent asthma or the like) and associated conditions (e.g., ABPA, ABPA comorbid with asthma, ABPA comorbid with cystic fibrosis (CF), ABPA comorbid with asthma and CF) in a subject are provided. Methods comprising administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof, are provided.


Find Patent Forward Citations

Loading…